Reagent price increases from dollar strength
Vendors have requested price increases due to dollar appreciation; if sustained, margins could be pressured unless passed on.
THYROCARETECHNOLOGIES / Q4-FY26 / risks
Keep the risk register visible.
Thyrocare Technologies · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
medium
Partnership business growth dip due to one-off normalization
Q4 partnership growth slowed to 23% due to normalization of insurance pricing and lower camp volumes; management attributes it to a one-off but it may recur.
Tanzania business still loss-making
Tanzania operations have not yet broken even after 18 months, with quarterly losses of ~₹1 crore, though minimal.
Specialty expansion may pressure near-term margins
Investments in specialty (genomics, allergy) will have lower gross margins initially, potentially weighing on overall profitability until scale is achieved.